|
|
Volumn 84, Issue 4, 1993, Pages 455-461
|
|
Effects of Chemoendocrine Therapy on the Coagulation‐Fibrinolytic Systems in Patients with Advanced Breast Cancer
|
|
Author keywords
Breast cancer; Coagulation; Fibrinolysis; Medroxyprogesterone acetate; Tamoxifen
|
|
Indexed keywords
ALPHA 2 ANTIPLASMIN;
ANTITHROMBIN III;
BLOOD CLOTTING FACTOR 10;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FIBRINOGEN;
MEDROXYPROGESTERONE ACETATE;
PLASMIN;
PLASMINOGEN;
PROTEIN C;
TAMOXIFEN;
THROMBIN;
TISSUE PLASMINOGEN ACTIVATOR;
ADULT;
AGED;
ARTICLE;
BLOOD CLOTTING;
BREAST CANCER;
CLINICAL TRIAL;
CONTROLLED STUDY;
ENZYME INHIBITOR COMPLEX;
FEMALE;
FIBRINOLYSIS;
HUMAN;
HYPERCOAGULABILITY;
INTRAVENOUS DRUG ADMINISTRATION;
LIVER DYSFUNCTION;
MAJOR CLINICAL STUDY;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
THROMBOPHLEBITIS;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BLOOD COAGULATION;
BREAST NEOPLASMS;
COMBINED MODALITY THERAPY;
COMPARATIVE STUDY;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FEMALE;
FIBRINOLYSIS;
HUMAN;
MEDROXYPROGESTERONE;
MEDROXYPROGESTERONE 17-ACETATE;
MIDDLE AGE;
PROSPECTIVE STUDIES;
TAMOXIFEN;
|
|
EID: 0027263033
PISSN: 09105050
EISSN: 13497006
Source Type: Journal
DOI: 10.1111/j.1349-7006.1993.tb00158.x Document Type: Article |
|
Times cited : (13)
|
|
References (15)
|
